Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.05B | 3.07B | 2.45B | 1.51B | 686.31M | Gross Profit |
1.96B | 570.60M | 1.58B | 997.60M | 450.85M | EBIT |
359.30M | 371.80M | 91.80M | -230.04M | -590.82M | EBITDA |
616.30M | 603.90M | 140.90M | -3.79M | -511.73M | Net Income Common Stockholders |
309.70M | 188.20M | -268.00M | -422.21M | -617.95M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.06B | 849.10M | 674.50M | 707.34M | 655.34M | Total Assets |
5.07B | 4.84B | 4.82B | 5.23B | 5.56B | Total Debt |
3.46B | 3.55B | 3.78B | 3.94B | 3.93B | Net Debt |
2.40B | 2.70B | 3.10B | 3.24B | 3.28B | Total Liabilities |
4.46B | 4.52B | 4.70B | 4.90B | 4.76B | Stockholders Equity |
594.40M | 309.80M | 110.20M | 322.90M | 787.97M |
Cash Flow | Free Cash Flow | |||
315.20M | 294.80M | 25.30M | 70.68M | -414.03M | Operating Cash Flow |
466.00M | 444.30M | 136.00M | 166.22M | -330.10M | Investing Cash Flow |
-146.90M | -131.80M | -96.30M | -89.30M | -83.37M | Financing Cash Flow |
-103.10M | -125.40M | -52.20M | -19.93M | 584.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $3.57B | 14.72 | 67.31% | 0.26% | -0.56% | 63.92% | |
70 Outperform | $1.15B | 44.87 | 9.00% | ― | -1.98% | -1.18% | |
62 Neutral | $525.72M | ― | -1.66% | 1.65% | 0.82% | -152.64% | |
59 Neutral | $13.76B | 7.65 | -2.18% | 3.85% | 2.32% | -36.56% | |
47 Neutral | $1.97B | ― | 168.75% | ― | -2.85% | 75.96% | |
45 Neutral | $1.16B | ― | 20.03% | ― | -3.64% | 48.94% | |
42 Neutral | $1.97B | ― | 259.47% | ― | -2.85% | 75.96% |
On May 2, 2025, Cinemark Holdings announced its financial results for the first quarter of 2025, reporting a total revenue of $541 million and a net loss of $39 million. Despite a challenging box office environment due to the lingering effects of the 2023 Hollywood strikes, Cinemark exceeded industry benchmarks both domestically and internationally. The company is optimistic about the industry’s recovery trajectory, with strong consumer enthusiasm for theatrical experiences. Cinemark also paid its first dividend since the pandemic and initiated a $200 million stock buyback program to manage potential dilution from convertible notes. The company entertained 37 million moviegoers globally and achieved significant market share growth in the U.S. and Latin America.
Spark’s Take on CNK Stock
According to Spark, TipRanks’ AI Analyst, CNK is a Outperform.
Cinemark Holdings shows strong recovery and resilience, driven by improving financial performance and positive earnings call insights. Technical indicators signal bullish momentum, while valuation metrics indicate reasonable pricing. Key strengths include revenue growth and market outperformance, though high leverage and rising costs pose risks.
To see Spark’s full report on CNK stock, click here.
On February 28, 2025, Cinemark Holdings entered into a new employment agreement with Ms. Wanda Gierhart, who has been with the company since 2018 in various marketing leadership roles. The agreement outlines her compensation, including a base salary of $575,000, eligibility for bonuses, and participation in the company’s equity incentive plan. The contract also details severance packages and benefits in the event of termination, ensuring Ms. Gierhart’s continued contribution to the company’s marketing strategies and operations.
Cinemark Holdings reported a robust financial performance for Q4 and FY 2024, with total revenue exceeding $3 billion and net income of $313 million. The company reinstated its annual cash dividend at $0.32 per share, emphasizing its recovery from the pandemic and commitment to shareholder value. Cinemark outperformed the North American industry box office and showed significant market share growth, despite challenges like the 2023 Hollywood Guild Strikes. The company also strengthened its balance sheet by retiring pandemic-related debt and reducing interest expenses.